[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368638-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368638-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-multifaceted-roles-of-mucins-family-in-lung-cancer-from-prognostic-biomarkers-to-promising-targets","The multifaceted roles of mucins family in lung cancer - from prognostic biomarkers to promising targets","","Lung cancer is a leading cause of cancer-related mortality worldwide, creating an urgent need for improved diagnosis and therapy. Mucins, epithelial glycoproteins that maintain barrier integrity and modulate immune responses, have emerged as both prognostic biomarkers and therapeutic targets in lung cancer. This review analyzes how mucin family members’ expression patterns and functions influence tumor progression and shape diagnostic and treatment strategies, while outlining remaining knowledge gaps and future research opportunities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-multifaceted-roles-of-mucins-family-in-lung-cancer-from-prognostic-biomarkers-to-promising-targets/368638/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-multifaceted-roles-of-mucins-family-in-lung-cancer-from-prognostic-biomarkers-to-promising-targets/368638.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are mucins considered important in lung cancer research?","Question",{"text":63,"@type":64},"Mucins are glycoproteins that help maintain epithelial integrity and regulate immune responses. In lung cancer, their expression patterns and functions are linked to tumor progression and clinical strategy development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is lung cancer commonly classified in the review?",{"text":68,"@type":64},"The review categorizes lung cancers into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC represents the majority of cases and SCLC is described as more aggressive.",{"name":70,"@type":61,"acceptedAnswer":71},"What treatment approaches and research hotspots are highlighted?",{"text":72,"@type":64},"The review describes surgery, chemotherapy, radiotherapy, and targeted therapy, and notes the role of immune checkpoint inhibitors (ICIs) as promising treatment directions, particularly for NSCLC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368638,1790639235,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","TYPE Review  \nPUBLISHED 27 June 2025  \nDOI 10.3389/fimmu.2025.1608140  \nOPEN ACCESS  \nEDITED BY  \nOraianthi Fiste,  \nNational and Kapodistrian University of Athens, Greece  \nREVIEWED BY  \nYanqiang Li,  \nBoston Children ’s Hospital and Harvard Medical School, United States Mukulika Bose,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nAruljothi Muralidharan,  \nUnited States Department of Veterans Affairs, United States  \nKasturi Banerjee, CSL, United States  \n*CORRESPONDENCE  \nDongbo Jiang  \n [superjames1991@foxmail.com](superjames1991@foxmail.com);  \n [superjames1991@fmmu.edu.cn](superjames1991@fmmu.edu.cn)[ ](superjames1991@fmmu.edu.cn)Kun Yang  \n[yangkunkun@fmmu.edu.cn](yangkunkun@fmmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 08 April 2025  \nACCEPTED 16 June 2025  \nPUBLISHED 27 June 2025  \nCITATION  \nYuan Q, Cai S, Chang Y, Zhang J, Wang M, Yang K and Jiang D (2025) The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets. Front. Immunol. 16:1608140 .  \ndoi: 10.3389/fimmu.2025.1608140  \nCOPYRIGHT  \n© 2025 Yuan, Cai, Chang, Zhang, Wang, Yang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe multifaceted roles of mucins family in lung cancer:  \nfrom prognostic biomarkers to promising targets  \nQinghong Yuan 1†, Sirui Cai 1†, Yuanhang Chang 1†, Junqi Zhang 1, Meng Wang 1, Kun Yang 1,2* and Dongbo Jiang 1,2,3*  \n1 Department of Immunology, Basic Medicine School, Air-Force Medical University (The Fourth Military Medical University), Xi’an, China, 2The Key Laboratory of Bio-Hazard Damage and Prevention Medicine, Basic Medicine School, Air-Force Medical University (The Fourth Military Medical University), Xi’an, China, 3 Department of Rehabilitation Medicine, Tangdu Hospital, Air-Force Medical University (The Fourth Military Medical University), Xi ’an, China  \nLung cancer remains one of the leading causes of cancer-related deaths worldwide, highlighting the urgent need for enhanced diagnostic and therapeutic strategies. Mucins, a family of glycoproteins crucial for maintaining epithelial integrity and regulating immune responses, have emerged as promising biomarkers and therapeutic targets in the context of lung cancer. The expression patterns and functional roles of mucin family members signiﬁcantly inﬂuencelung cancer progression, thereby shaping diagnostic and therapeutic approaches for this disease. A more detailed classiﬁcation of mucin family members could facilitate diagnosis and patient assessments, as well as help identify potential therapeutic targets. This review thoroughly examines the latest advancements in understanding the role of mucins in lung cancer progression, prognosis, and treatment, while also highlighting knowledge gaps and opportunities for future research, thus providing new perspectives for the management of this disease.  \nKEYWORDS  \nmucins, lung cancer, biomarkers, targets, prognosis, therapeutics  \n1 Introduction  \nLung cancers, the primary causes of cancer-related deaths globally, are a group of malignancies that develop from bronchial epithelial cells (1) . According to data from the International Agency for Research on Cancer (IARC) of World Health Organization, the incidence of lung cancer is increasing annually, particularly in developing nations (2) . Despite signiﬁcant progress in diagnosing and treating lung cancers, the ﬁve-year survival rate after diagnosis remains less than desirable (3–5). The main difﬁculty lies in detecting lung cancer early, as it frequently advances to a late stage","cbCaipVmI81wFiWz","https://ap.wps.com/l/cbCaipVmI81wFiWz","pdf",1978497,27,"English","# Introduction\n## Classification and epidemiology\n## Current treatment approaches and research hotspots","[{\"question\":\"Why are mucins considered important in lung cancer research?\",\"answer\":\"Mucins are glycoproteins that help maintain epithelial integrity and regulate immune responses. In lung cancer, their expression patterns and functions are linked to tumor progression and clinical strategy development.\"},{\"question\":\"How is lung cancer commonly classified in the review?\",\"answer\":\"The review categorizes lung cancers into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC represents the majority of cases and SCLC is described as more aggressive.\"},{\"question\":\"What treatment approaches and research hotspots are highlighted?\",\"answer\":\"The review describes surgery, chemotherapy, radiotherapy, and targeted therapy, and notes the role of immune checkpoint inhibitors (ICIs) as promising treatment directions, particularly for NSCLC.\"}]","The multifaceted roles of mucins family in lung cancer - from prognostic biomarkers to promising targets | PDF",1790177808,68,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/317ca6bffc69ad6185fc165b771281ee.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45361ad917d1e79bc7f8b11c7cc6f16f.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/678ef20b0825c38188331cffe9ff5c17.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19609022ede865c3fcd03565d2a3d573.webp",980,1385]